The time interval between injection of nicotine and tremor initiation: a new index for evaluating nicotine efficacy in rodents

References

• Abbaszadeh-Kasbi A, Haddadi N-S, Dehdashtian A, Afshari K, Jazaeri SZ, Khodaei N, Momeni M, Dehpour A-R. 2019. Acute activation of α7-nicotinic receptors by nicotine improves rodent skin flap survival through nitrergic system. Ann Plast Surg. 83(2):211–216. doi: 10.1097/SAP.0000000000001809.
   PubMed Web of Science ®Google Scholar
• Beleslin DB, Krstić SK. 1986. Nicotine-induced convulsions in cats and central nicotinic receptors. Pharmacol Biochem Behav. 24(6):1509–1511. doi: 10.1016/0091-3057(86)90476-4.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Hukkanen J, Jacob P 3rd. 2009. Nicotine chemistry, metabolism, kinetics and biomarkers. In: Henningfield JE, et al., editors. Nicotine Psychopharmacology, Handbook of experimental pharmacology 192. Springer-Verlag Berlin Heidelberg; p. 29–60. doi: 10.1007/978-3-540-69248-5_2.
   Google Scholar
• Chen C-Y, Papadopoulos KD. 2020. Temperature and salting out effects on nicotine dissolution kinetics in saline solutions. ACS Omega. 5(14):7738–7744. doi: 10.1021/acsomega.9b02836.
   PubMed Web of Science ®Google Scholar
• Fagerström K. 2014. Nicotine: pharmacology, toxicity and therapeutic use. J Smok Cessat. 9(2):53–59. doi: 10.1017/jsc.2014.27.
   Google Scholar
• Gomita Y, Suemaru K, Furuno K, Araki Y. 1991. Tail-tremor induced by exposure to cigarette smoke in rats. Pharmacol Biochem Behav. 40(2):453–455.
   PubMed Web of Science ®Google Scholar
• Govind AP, Vezina P, Green WN. 2009. Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol. 78(7):756–765. doi: 10.1016/j.bcp.2009.06.011.
   PubMed Web of Science ®Google Scholar
• Hirano T, Shobayashi T, Takei T, Wakao F. 2020. Exposure assessment of environmental tobacco aerosol from heated tobacco products: nicotine and PM exposures under two limited conditions. Int J Environ Res Public Health. 17(22):8536.
   PubMed Web of Science ®Google Scholar
• Jurado-Coronel JC, Avila-Rodriguez M, Capani F, Gonzalez J, Moran VE, Barreto GE. 2016. Targeting the nicotinic acetylcholine receptors (nAChRs) in astrocytes as a potential therapeutic target in Parkinson’s disease. Curr Pharm Des. 22(10):1305–1311.
   PubMed Web of Science ®Google Scholar
• Kato M, Kunisawa N, Shimizu S, Iha HA, Ohno Y. 2022. Mechanisms underlying dopaminergic regulation of nicotine-induced kinetic tremor. Front Pharmacol. 13:938175. doi: 10.3389/fphar.2022.938175.
   PubMed Web of Science ®Google Scholar
• Kunisawa N, Iha HA, Nomura Y, Onishi M, Matsubara N, Shimizu S, Ohno Y. 2017. Serotonergic modulation of nicotine-induced kinetic tremor in mice. J Pharmacol Sci. 134(2):131–138. doi: 10.1016/j.jphs.2017.06.001.
   PubMed Web of Science ®Google Scholar
• Kunisawa N, Iha HA, Shimizu S, Tokudome K, Mukai T, Kinboshi M, Serikawa T, Ohno Y. 2016. Nicotine evokes kinetic tremor by activating the inferior olive via α7 nicotinic acetylcholine receptors. Behav Brain Res. 314:173–180. doi: 10.1016/j.bbr.2016.08.013.
   PubMed Web of Science ®Google Scholar
• Kunisawa N, Shimizu S, Kato M, Iha HA, Iwai C, Hashimura M, Ogawa M, Kawaji S, Kawakita K, Abe K, et al. 2018. Pharmacological characterization of nicotine-induced tremor: responses to anti-tremor and anti-epileptic agents. J Pharmacol Sci. 137(2):162–169. doi: 10.1016/j.jphs.2018.05.007.
   PubMed Web of Science ®Google Scholar
• Kyerematen GA, Taylor LH, deBethizy JD, Vesell ES. 1988. Pharmacokinetics of nicotine and 12 metabolites in the rat. Application of a new radiometric high performance liquid chromatography assay. Drug Metab Dispos. 16(1):125–129.
   PubMed Web of Science ®Google Scholar
• Ma C, Liu Y, Neumann S, Gao X. 2017. Nicotine from cigarette smoking and diet and Parkinson disease: a review. Transl Neurodegener. 6(1):18. doi: 10.1186/s40035-017-0090-8.
   PubMedGoogle Scholar
• Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, et al. 2007. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology. 190(3):269–319. doi: 10.1007/s00213-006-0441-0.
   PubMed Web of Science ®Google Scholar
• Ohtsuki S, Terasaki T. 2007. Contribution of carrier-mediated transport systems to the blood–brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm Res. 24(9):1745–1758. doi: 10.1007/s11095-007-9374-5.
   PubMed Web of Science ®Google Scholar
• Rose JE, Behm FM, Westman EC, Coleman RE. 1999. Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: implications for addiction. Drug Alcohol Depend. 56(2):99–107. doi: 10.1016/s0376-8716(99)00025-3.
   PubMed Web of Science ®Google Scholar
• Silvette H, Hoff EC, Larson PS, Haag HB. 1962. The actions of nicotine on central nervous system functions. Pharmacol Rev. 14:137–173.
   PubMed Web of Science ®Google Scholar
• Stone CA, Meckelnburg KL, Torchiana ML. 1958. Antagonism of nicotine-induced convulsions by ganglionic blocking agents. Arch Int Pharmacodyn Ther. 117(3–4):419–434.
   PubMedGoogle Scholar
• Tega Y, Yamazaki Y, Akanuma S-I, Kubo Y, Hosoya K-I. 2018. Impact of nicotine transport across the blood–brain barrier: carrier-mediated transport of nicotine and interaction with central nervous system drugs. Biol Pharm Bull. 41(9):1330–1336. doi: 10.1248/bpb.b18-00134.
   PubMed Web of Science ®Google Scholar
• Tizabi Y, Getachew B, Aschner M. 2021. Novel pharmacotherapies in Parkinson’s disease. Neurotox Res. 39(4):1381–1390. doi: 10.1007/s12640-021-00375-5.
   PubMed Web of Science ®Google Scholar